Home/Filings/4/0001415889-24-001872
4//SEC Filing

Dayno Jeffrey M. 4

Accession 0001415889-24-001872

CIK 0001802665other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 4:56 PM ET

Size

8.1 KB

Accession

0001415889-24-001872

Insider Transaction Report

Form 4
Period: 2024-01-24
Dayno Jeffrey M.
DirectorPRESIDENT, CEO
Transactions
  • Award

    Restricted Stock Units

    2024-01-24+42,00042,000 total
    Common Stock (42,000 underlying)
  • Award

    Stock Option

    2024-01-24+202,250202,250 total
    Exercise: $30.69Exp: 2034-01-24Common Stock (202,250 underlying)
Footnotes (2)
  • [F1]The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F2]The restricted stock units shall vest in four equal annual installments beginning January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

Issuer

Harmony Biosciences Holdings, Inc.

CIK 0001802665

Entity typeother

Related Parties

1
  • filerCIK 0001615993

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:56 PM ET
Size
8.1 KB